EA200000062A1 - Фармацевтические композиции, содержащие шипучую кислотно-основную пару - Google Patents

Фармацевтические композиции, содержащие шипучую кислотно-основную пару

Info

Publication number
EA200000062A1
EA200000062A1 EA200000062A EA200000062A EA200000062A1 EA 200000062 A1 EA200000062 A1 EA 200000062A1 EA 200000062 A EA200000062 A EA 200000062A EA 200000062 A EA200000062 A EA 200000062A EA 200000062 A1 EA200000062 A1 EA 200000062A1
Authority
EA
Eurasian Patent Office
Prior art keywords
acid
speaker
pharmaceutical compositions
compositions containing
basic pair
Prior art date
Application number
EA200000062A
Other languages
English (en)
Other versions
EA002608B1 (ru
Inventor
Паоло Кьези
Паоло Вентура
Роза Меццадри
Гаэтано Брамбилла
Даниэла Ачерби
Original Assignee
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. filed Critical КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А.
Publication of EA200000062A1 publication Critical patent/EA200000062A1/ru
Publication of EA002608B1 publication Critical patent/EA002608B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Фармацевтическая композиция в форме шипучих таблеток, содержащая активный ингредиент и шипучую смесь, которая содержит кислотный компонент и натрий-глицин карбонат в качестве щелочных компонентов. Предпочтительно, кислотным компонентом являются фумаровая кислота, малеиновая кислота и их соли. Таблетки готовят прямым прессованием в нормальныхных термо-гигрометрических условиях и с помощью стандартного таблетирующего оборудования.Отчет о международном поиске был опубликован 1999.06.10.
EA200000062A 1997-07-23 1998-07-23 Фармацевтические композиции, содержащие шипучую кислотно-основную пару EA002608B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001746A IT1293764B1 (it) 1997-07-23 1997-07-23 Composizioni farmaceutiche sotto forma di compresse effervescenti contenenti un principio attivo instabile in presenza di acqua
PCT/EP1998/004517 WO1999004765A2 (en) 1997-07-23 1998-07-23 Pharmaceutical compositions containing an effervescent acid-base couple

Publications (2)

Publication Number Publication Date
EA200000062A1 true EA200000062A1 (ru) 2000-10-30
EA002608B1 EA002608B1 (ru) 2002-06-27

Family

ID=11377613

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200000062A EA002608B1 (ru) 1997-07-23 1998-07-23 Фармацевтические композиции, содержащие шипучую кислотно-основную пару

Country Status (27)

Country Link
US (1) US6284272B1 (ru)
EP (1) EP1003486B1 (ru)
JP (1) JP4801255B2 (ru)
KR (1) KR100528141B1 (ru)
CN (1) CN1138535C (ru)
AT (1) ATE232092T1 (ru)
AU (1) AU743186B2 (ru)
BG (1) BG64074B1 (ru)
BR (1) BR9801335B1 (ru)
CZ (1) CZ296221B6 (ru)
DE (1) DE69811236T2 (ru)
DK (1) DK1003486T3 (ru)
EA (1) EA002608B1 (ru)
ES (1) ES2191960T3 (ru)
HK (1) HK1029525A1 (ru)
HU (1) HU226115B1 (ru)
IL (1) IL134166A (ru)
IT (1) IT1293764B1 (ru)
NO (1) NO326639B1 (ru)
NZ (1) NZ502479A (ru)
OA (1) OA10999A (ru)
PL (1) PL199164B1 (ru)
PT (1) PT1003486E (ru)
SI (1) SI1003486T1 (ru)
SK (1) SK284551B6 (ru)
TR (1) TR199900675T1 (ru)
WO (1) WO1999004765A2 (ru)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040151768A1 (en) * 1997-07-23 2004-08-05 Chiesi Farmaceutici S.P.A. Pharmaceutical compositions containing an effervescent acid-base couple
FR2786395A1 (fr) * 1998-12-01 2000-06-02 Virbac Sa Compositions seches solubles en presence d'eau et evitant la reaction de maillard a l'etat sec, leur preparation et leurs applications
CA2378525A1 (en) * 1999-07-02 2001-01-11 Sca Lohnherstellungs Ag A solid formulation of glucosamine sulphate
WO2001010405A1 (en) * 1999-08-04 2001-02-15 Ranbaxy Laboratories Limited Hydrodynamically balanced oral drug delivery system
IN190018B (ru) * 1999-09-28 2003-05-31 Panacea Biotec Ltd
GB0006897D0 (en) * 2000-03-23 2000-05-10 Smithkline Beecham Plc Medicaments
ATE329583T1 (de) * 2000-08-18 2006-07-15 Pharmacia Corp Schnell zerfallende orale arzneizubereitung enthaltend valdecoxib
CN1638739A (zh) * 2000-08-18 2005-07-13 法玛西雅厄普约翰美国公司 治疗成瘾性障碍的化合物
US6531153B2 (en) * 2001-05-29 2003-03-11 Drugtech Corporation Composition with sustained release of levodopa and carbidopa
US6762153B2 (en) * 2001-10-18 2004-07-13 Rohm And Haas Company Delivery system for cyclopropenes
US20030091627A1 (en) * 2001-10-31 2003-05-15 Vinay Sharma Rate-controlled delivery of macrolides
KR100456273B1 (ko) 2001-11-16 2004-11-10 김용년 산과 반응하여 일정 속도로 이산화탄소를 발생시킬 수있는 고상 제제 및 그의 제조 방법
US7488496B2 (en) * 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
CA2495886C (en) 2002-03-06 2011-05-03 Lifizz, Inc. Effervescent compositions comprising bisphosphonates and methods related thereto
BG730Y1 (bg) * 2003-03-20 2005-04-30 Владимир НАЙДЕНОВ Ефервесцентна лекарствена форма
CN100445263C (zh) * 2003-04-24 2008-12-24 四川大学 甘氨酸钠碳酸盐的微波合成方法
SI2260871T1 (sl) 2004-04-01 2013-09-30 Pierre Fabre Medicament Kompleksi sestavin, ki vključujejo piroksikam, ciklodekstrin in arginin
FR2876911B1 (fr) * 2004-10-21 2007-04-13 Pierre Fabre Medicament Sa Complexe comprenant du piroxicam, une cyclodextrine et de l'arginine
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20080287456A1 (en) * 2004-05-28 2008-11-20 Imaginot Pty Ltd Oral Therapeutic Compound Delivery System
EP1901720A2 (en) * 2005-06-23 2008-03-26 Spherics, Inc. Improved dosage forms for movement disorder treatment
CN100341488C (zh) * 2005-11-22 2007-10-10 瑞普（保定）生物药业有限公司 一种饮水免疫泡腾片及其制备方法
AU2006317530B2 (en) * 2005-11-28 2011-09-01 Imaginot Pty Ltd Oral therapeutic compound delivery system
US20080131492A1 (en) * 2006-06-23 2008-06-05 Spherics, Inc. Dosage forms for movement disorder treatment
WO2008079404A2 (en) * 2006-12-22 2008-07-03 Combinatorx, Incorporated Pharmaceutical compositions for treatment of parkinson's disease and related disorders
CA2686035C (en) * 2007-05-08 2016-01-05 Hercules Incorporated Robust rapid disintegration tablet formulation
CN101910113A (zh) 2007-12-28 2010-12-08 怡百克制药公司 左旋多巴控释制剂及其用途
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
CN102099017A (zh) 2008-07-21 2011-06-15 雅宝公司 高含量布洛芬钠颗粒、其制备及其在制备非泡腾固体剂型中的用途
EP2547221B1 (en) * 2010-03-13 2014-12-17 Eastpond Laboratories Limited Fat-binding compositions
CN101836951B (zh) * 2010-05-20 2013-06-05 山东达因海洋生物制药股份有限公司 一种含盐酸氨溴索的口服溶液及其制备方法
CN102322123B (zh) * 2011-06-30 2013-09-18 德清艺玛工艺装饰有限公司 一种仿大理石泡沫装饰材料
CN102398378A (zh) * 2011-11-03 2012-04-04 北京华禧联合科技发展有限公司 镀铬冲模在硫酸氢氯吡格雷片制备过程中的应用
BR112015013945A8 (pt) * 2012-12-14 2019-10-08 Si Group Inc grânulos de alto teor de ibuprofeno de sódio, preparação do mesmo e uso do mesmo na preparação de formas de dosagem sólidas não-efervescentes
US10987313B2 (en) 2013-10-07 2021-04-27 Impax Laboratories, Llc Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
WO2015054302A1 (en) 2013-10-07 2015-04-16 Impax Laboratories, Inc. Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof
EP2870961B1 (en) * 2013-11-06 2018-07-18 Sanovel Ilac Sanayi ve Ticaret A.S. Effervescent formulations of pramipexole
MA52122A (fr) 2018-03-02 2021-04-28 Chiesi Farm Spa Formulation pharmaceutique pour administration intraduodénale comprenant de la mélévodopa et de la carbidopa
US11986449B2 (en) 2020-12-22 2024-05-21 Amneal Pharmaceuticals Llc Levodopa dosing regimen

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1196033B (it) * 1984-02-22 1988-11-10 Chiesi Farma Spa Composto ad attivita' antiinfiammatoria ottenuto per complessazione con beta-ciclodestrina e relative formulazioni farmaceutiche
EP0252290B1 (en) * 1986-06-10 1992-06-03 CHIESI FARMACEUTICI S.p.A. Pharmaceutical compositions containing levodopa methyl ester, preparation and therapeutic applications thereof
CH675537A5 (ru) * 1988-03-25 1990-10-15 Ciba Geigy Ag
DE3838431A1 (de) * 1988-11-12 1990-05-17 Bayer Ag Ibuprofen-brausezubereitungen
DE69102900T3 (de) * 1990-02-14 1998-04-09 Otsuka Pharma Co Ltd Brausemischung, deren Herstellung sowie Verwendung.
US5252341A (en) * 1990-07-16 1993-10-12 Degussa Aktiengesellschaft Tablets and granulates containing mesna as active substance
JP2910425B2 (ja) * 1992-06-17 1999-06-23 和光純薬工業株式会社 発泡性錠剤の新規な製造方法
JP3170139B2 (ja) * 1994-04-08 2001-05-28 エスエス製薬株式会社 発泡性錠剤
FR2733420B1 (fr) * 1995-04-28 1997-06-27 Sep Tarral Preparations pectiques utilisables comme support de medicament
AU712710B2 (en) * 1996-05-17 1999-11-11 Merck Sharp & Dohme Corp. Effervescent bisphosphonate formulation

Also Published As

Publication number Publication date
TR199900675T1 (xx) 1999-11-22
JP4801255B2 (ja) 2011-10-26
AU743186B2 (en) 2002-01-17
US6284272B1 (en) 2001-09-04
WO1999004765A3 (en) 1999-06-10
NO991376D0 (no) 1999-03-22
ES2191960T3 (es) 2003-09-16
PL338502A1 (en) 2000-11-06
EP1003486B1 (en) 2003-02-05
DE69811236T2 (de) 2003-10-30
SK284551B6 (sk) 2005-06-02
EA002608B1 (ru) 2002-06-27
HK1029525A1 (en) 2001-04-06
ITMI971746A1 (it) 1999-01-23
EP1003486A2 (en) 2000-05-31
KR20010022140A (ko) 2001-03-15
NO991376L (no) 1999-05-25
ATE232092T1 (de) 2003-02-15
CN1138535C (zh) 2004-02-18
WO1999004765A2 (en) 1999-02-04
NZ502479A (en) 2002-02-01
SK922000A3 (en) 2000-07-11
OA10999A (en) 2001-11-07
HUP0003897A2 (hu) 2001-08-28
CZ2000255A3 (cs) 2000-07-12
CZ296221B6 (cs) 2006-02-15
BR9801335B1 (pt) 2010-09-21
IL134166A (en) 2005-08-31
HUP0003897A3 (en) 2006-06-28
SI1003486T1 (en) 2003-08-31
JP2001510789A (ja) 2001-08-07
KR100528141B1 (ko) 2005-11-15
DE69811236D1 (de) 2003-03-13
DK1003486T3 (da) 2003-05-19
BR9801335A (pt) 1999-05-04
NO326639B1 (no) 2009-01-26
PL199164B1 (pl) 2008-08-29
PT1003486E (pt) 2003-06-30
BG64074B1 (bg) 2003-12-31
AU8977798A (en) 1999-02-16
IL134166A0 (en) 2001-04-30
IT1293764B1 (it) 1999-03-10
BG103253A (en) 1999-09-30
CN1267215A (zh) 2000-09-20
HU226115B1 (en) 2008-04-28

Similar Documents

Publication Publication Date Title
EA200000062A1 (ru) Фармацевтические композиции, содержащие шипучую кислотно-основную пару
EA199900026A1 (ru) Быстрорастворимая таблетка гидробромида галантамина
EE03089B1 (et) Ibuprofeeni sisaldav kihisev ravimpreparaat ja selle valmistamise meetod
PT893992E (pt) Formas de dosagem oral de desintegracao rapida
CA2411754A1 (en) 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoic acid and compositions for delivering active agents
EA199800936A1 (ru) Грануляты гидролизованной целлюлозы для фармацевтических препаратов
AU2001291731A1 (en) Pharmaceutical, effervescent formulation containing ramipril
WO2003028624A3 (en) Levothyroxine compositions and methods
ZA913344B (en) Substituted indoles
CA2297673A1 (en) Pharmaceutical compositions containing an effervescent acid-base couple
WO2003013441A3 (en) Levothyroxine compositions and methods
ES2126474A1 (es) Procedimiento para la preparacion de composiciones orales que contienn quinolonas
PL323624A1 (en) Novel purgative compositions and methods of manufacturing them
MXPA03007332A (es) Composiciones de levotiroxina y metodos para elaborar la misma.
JO1843B1 (en) Benzimercool vehicles carry alternatives and processes for their preparation and use in a pharmacy

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU